Refreshing results…
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study
UploadObinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA
UploadMissing publications? Search for publications with a matching author name.